Log in

News

  • Home
  • Resources
  • Literature Updates
  • Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial

Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial

15 Mar 2021 8:11 PM | ISDE Office (Administrator)

Prof Rebecca C Fitzgerald, MD; Massimiliano di Pietro, MD; Maria O'Donovan, MD; Roberta Maroni, MSc; Beth Muldrew, MA; Irene Debiram-Beecham, RN et al.

Read the full abstract...

Affiliated Societies



International  Interdisciplinary  Everything Esophageal


The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software